. 2019 Jul 30;25(1):e12678. doi: 10.1111/anec.12678

Table 2.

Logistic regression spatial QRS|T angle as classified by Whang et al. with MetS, stratified by gender

	Men				Women
	Unadjusted Analysis N = 2,904		Adjusted Analysis^a N = 2,904		Unadjusted Analysis N = 3,345		Adjusted Analysis^a N = 3,345
	Borderline (n = 639) versus normal (n = 2,079) OR (95% CI)	Abnormal (n = 186) versus normal (n = 2,079) OR (95% CI)	Borderline (n = 639) versus normal (n = 2,079) OR (95% CI)	Abnormal (n = 186) versus normal (n = 2,079) OR (95% CI)	Borderline (n = 690) versus normal (n = 2,420) OR (95% CI)	Abnormal (n = 235) versus normal (n = 2,420) OR (95% CI)	Borderline (n = 690) versus normal (n = 2,420) OR (95% CI)	Abnormal (n = 235) versus normal (n = 2,420) OR (95% CI)
Metabolic syndrome
No	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
Yes	1.11 (0.80–1.54)	2.48 (1.42–4.33)	1.01 (0.73–1.39)	1.83 (1.07–3.13)	1.64 (1.23–2.20)	3.00 (2.14–4.20)	1.42 (1.04–1.95)	2.30 (1.64–3.22)
Number components present
0	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
1	0.96 (0.60–1.55)	1.56 (0.56–4.37)	0.90 (0.54–1.48)	1.14 (0.37–3.50)	1.14 (0.78–1.64)	1.74 (0.78–3.88)	1.06 (0.74–1.53)	1.39 (0.61–3.19)
2	0.94 (0.59–1.48)	1.69 (0.52–5.46)	0.79 (0.47–1.31)	0.99 (0.30–3.26)	1.19 (0.78–1.81)	1.43 (0.56–3.64)	1.04 (0.70–1.54)	1.09 (0.42–2.82)
3	1.01 (0.53–1.94)	3.14 (1.18–8.35)	0.83 (0.43–1.62)	1.63 (0.57–4.66)	1.59 (1.03–2.46)	3.81 (1.89–7.65)	1.35 (0.86–2.13)	2.51 (1.24–5.09)
4+	1.15 (0.68–1.93)	4.26 (1.53–11.83)	0.94 (0.53–1.67)	2.36 (0.77–7.21)	2.16 (1.37–3.39)	4.91 (2.62–9.21)	1.66 (1.04–2.66)	3.09 (1.57–6.08)
Number of Components Present	1.03 (0.91–1.17)	1.43 (1.16–1.78)	0.98 (0.86–1.12)	1.26 (1.02–1.60)	1.21 (1.08–1.35)	1.49 (1.34–1.66)	1.14 (1.01–1.28)	1.35 (1.20–1.51)
Elevated blood pressure ^b
No	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
Yes	1.34 (0.93–1.94)	2.73 (1.63–4.59)	1.26 (0.86–1.86)	1.86 (1.04–3.31)	1.48 (1.15–1.89)	2.88 (1.88–4.40)	1.35 (1.06–1.72)	2.21 (1.48–3.29)
Impaired fasting blood glucose^c
No	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
Yes	1.24 (0.94–1.64)	2.57 (1.61–4.12)	1.21 (0.92–1.59)	2.40 (1.46–3.94)	1.51 (1.13–2.00)	1.92 (1.33–2.75)	1.38 (1.04–1.83)	1.62 (1.09–2.39)
Decreased high‐density lipoprotein cholesterol^d
No	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
Yes	1.06 (0.78–1.46)	1.35 (0.77–2.38)	0.99 (0.72–1.37)	1.15 (0.64–2.06)	1.31 (1.01–1.69)	1.94 (1.34–2.83)	1.17 (0.89–1.53)	1.61 (1.06–2.45)
Elevated triglycerides ^e
No	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
Yes	0.83 (0.64–1.06)	1.03 (0.71–1.51)	0.78 (0.59–1.03)	0.92 (0.58–1.45)	Ref1.59 (1.23–2.06)	1.53 (1.18–1.98)	1.40 (1.03–1.91)	1.28 (0.89–1.84)
Abdominal obesity^f
No	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
Yes	0.86 (0.66–1.14)	1.87 (1.10–3.21)	0.73 (0.55–0.97)	1.18 (0.63–2.24)	1.23 (0.92–1.64)	2.11 (1.46–3.06)	1.04 (0.76–1.44)	1.72 (1.10–2.69)
Systolic blood pressure, 10 mm Hg	1.19 (1.10–1.30)	1.39 (1.25–1.56)	1.22 (1.10–1.35)	1.34 (1.17–1.53)	1.17 (1.10–1.23)	1.31 (1.21–1.42)	1.20 (1.14–1.26)	1.30 (1.16–1.45)
Diastolic blood pressure, 10 mm Hg	1.20 (1.06–1.36)	1.22 (0.95–1.56)	1.24 (1.06–1.44)	1.25 (0.95–1.63)	1.24 (1.09–1.40)	1.24 (0.97–1.58)	1.19 (1.04–1.37)	1.27 (0.98–1.65)
Fasting blood glucose, 10 mg/dl	1.03 (0.99–1.07)	1.11 (1.08–1.15)	1.02 (0.98–1.06)	1.10 (1.05–1.14)	1.07 (1.04–1.10)	1.09 (1.07–1.12)	1.06 (1.03–1.09)	1.08 (1.05–1.11)
High‐density lipoprotein cholesterol, 10 mg/dl	1.02 (0.92–1.13)	1.02 (0.83–1.26)	1.05 (0.94–1.17)	1.09 (0.87–1.34)	0.98 (0.91–1.05)	0.88 (0.77–0.99)	1.01 (0.93–1.09)	0.93 (0.83–1.04)
Triglycerides, 10 mg/dl	0.99 (0.98–1.00)	0.99 (1.01–1.03)	0.99 (0.98–1.00)	1.02 (1.01–1.03)	1.01 (1.00–1.03)	1.02 (1.00–1.03)	1.01 (1.00–1.02)	1.01 (1.00–1.03)
Waist circumference, 10 cm	0.92 (0.82–1.03)	1.16 (0.97–1.39)	0.85 (0.75–0.96)	0.97 (0.75–1.26)	1.05 (0.96–1.15)	1.23 (1.10–1.36)	0.98 (0.88–1.09)	1.16 (1.02–1.31)

Adjusted for age, race, heart rate, smoking, PR interval, corrected QT interval (Fridericia formula), QRS interval, and QRS amplitude.

Participants who had systolic blood pressure >130 mm Hg, diastolic blood pressure >85 mm Hg blood pressure, and/or self‐reported a diagnosis of hypertension or use of antihypertensive medications.

Participants who had a fasting blood glucose >100 mg/dl and/or self‐reported a diagnosis of diabetes or use of medication for diabetes.

High‐density lipoprotein (HDL) <40 mg/dl for males and HDL <50 mg/dl for females.

Elevated triglycerides >150 mg/dl.

Waist circumferences >102 cm for males or >88 cm for females.